Malaria kills more than half a million people every year. Following a number of groundbreaking clinical trials, Professor Nick White and his Thailand team successfully demonstrated the effectiveness of artemisinin drug therapy for malaria in adults, children and infants. He also pioneered artemisinin combination therapy, the first-line treatment for malaria worldwide.
Understanding great research doesn’t have to be confusing. In this series of podcasts, our researchers explain what they get up to for a general audience.
Malaria is one of the world’s biggest killers. And our best weapon against it is at risk. We’re in a race against evolution – but what happens if we lose? This episode from The Economist series of 'The World if...' imagines what might happen if drug-resistant malaria spreads to Africa in the near future.